IL3 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Integra Lifesciences Holdings Corp

Watchlist Manager

Watchlist

Price: 9.6 EUR 5.49%

Market Cap: €2B

I	Integra Lifesciences Holdings Corp SWB:IL3	US
	Celanese Corp NYSE:CE	US
	CapitaLand Integrated Commercial Trust SGX:C38U	SG
M	MGIC Investment Corp SWB:MGC	US
K	Koninklijke Philips NV XBER:PHI1	NL
L	Lubelski Wegiel Bogdanka SA XMUN:UXX	PL
	Lovesac Co NASDAQ:LOVE	US
C	Conmed Corp SWB:EC8	US
C	Celanese Corp SWB:DG3	US
G	Gilead Sciences Inc MIL:GILD	US
K	Koninklijke DSM NV XBER:DSM2	NL
P	Packaging Corp of America F:PKA	US
	R E A Holdings PLC F:BY0	UK

Profitability Summary

Integra Lifesciences Holdings Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

57%

Strong 3Y Average Gross Margin

60%

Declining Gross Margin

63% > 57%

Healthy Operating Margin

11%

Sustainable 3Y Average Operating Margin

13%

Declining Operating Margin

18% > 11%

Negative Net Margin

-30%

Negative 3Y Average Net Margin

-8%

Declining Net Margin

8% > -30%

Negative Free Cash Flow Margin

-1%

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

10% > -1%

Negative ROE

-39%

Negative 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.